06.03.2021
Prevent & Delay
$969,323.00
48 months
Defining the efficacy and mechanisms of peptide immunotherapy for type 1 diabetes: an experimental medicine study
The funds support a first-in-human mechanistic study with a peptide immunotherapy for type 1 diabetes.